On 4–5 October, Team Lockton once again joined hundreds of passionate riders for the MACA Cancer 200- Ride for the Perkins, marking our 10th consecutive year supporting the Harry Perkins Institute of Medical Research.
The MACA Cancer 200 - Ride for the Perkins is a two-day, 200-kilometre round-trip cycling challenge from Perth to Mandurah and back. Every participant rides with purpose, fundraising to support life-saving cancer research.
We're incredibly proud to share that Team Lockton raised $86,998 this year, bringing our total contribution over the past decade to just under $600,000. We also maintained our position among the Top 20 Corporate Team donations, a testament to the dedication of our riders, supporters, and sponsors.
This year, our riders braved wet and windy conditions on the 100-kilometre journey to Mandurah on Saturday, but spirits remained high as we rode together for a cause close to all our hearts. Day 2 was much kinder, with clear skies and a 25km tailwind helping the remaining 10 riders cover the 100 kilometres back from Mandurah, into Optus Stadium to finish.
As Australia's largest charity bike ride, the MACA Cancer 200 has now raised over $74 million for the Harry Perkins Institute, with a single united goal: to make cancer non-lethal. Team Captain Nikki Oliver expressed: "Unfortunately, this cruel disease has impacted all of us at some point in our lives or will. We continue to wholeheartedly support the event not only as a business, but as a group of individuals who have been affected by cancer and want to make a difference personally."
Thank you to our sponsors
This milestone year would not have been possible without the incredible generosity of our sponsors. Your support drives meaningful impact.
DIAMOND SPONSOR
PLATINUM SPONSORS
GOLD SPONSORS
To everyone who donated, sponsored, or cheered us on, thank you for being part of our 10-year journey. Together, we continue to ride for a future free from cancer.
The contents of this publication are provided for general information only. Lockton arranges the insurance and is not the insurer. While the content contributors have taken reasonable care in compiling the information presented, we do not warrant that the information is correct. It is not intended to be interpreted as advice on which you should rely and may not necessarily be suitable for you. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content in this publication.